-
1 × $199.00 -
1 × $165.00 -
-
1 × $365.00 -
2 × $109.00 -
1 × $209.00 -
1 × $159.00 -
1 × $1,269.00 -
1 × $269.00 -
1 × $125.00 -
1 × $109.00 -
1 × $349.00 -
1 × $996.00 -
1 × $145.00 -
1 × $139.00 -
1 × $997.00 -
1 × $272.00 -
1 × $278.00 -
1 × $1.50 -
1 × $105.00 -
1 × $69.00 -
2 × $193.00 -
1 × $731.00 -
1 × $599.00 -
1 × $66.00 -
1 × $2.60 -
1 × $199.00 -
1 × $1,550.00 -
1 × $254.00 -
1 × $179.00 -
1 × $866.00 -
1 × $666.00 -
1 × $69.00 -
2 × $15.00 -
1 × $1,398.00 -
1 × $286.00 -
1 × $29.90
Velasof (EPCLUSA) Sofosbuvir/Velpatasvir online
Roll over image to zoom in
Velasof, also known as “EPCLUSA®, Velpanat, MyHep All, Hepcvel, Sofosvel” is a fixed dose combination medication for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1, 2, 3, 4, 5, or 6 infections without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis. Velasof combines Sofosbuvir 400mg and velpatasvir 100mg. It is more than 90% effective for hepatitis C. Sofosbuvir 400mg/Velpatasvir 100 mg’s brand name is EPCLUSA® by Gilead. Velasof is a generic oncologic prescription medicine from Hetero, which is one of the biggest pharmaceutical company in India.
Reviews
There are no reviews yet.